Rhythm Pharmaceuticals ceo salary
David P. Meeker, Chief Executive Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM), received $14,663,742 ($14.7M) in total compensation for FY2024, up 102.8% from the prior year. Option awards of $8,784,115 were the largest component. Figures come from RHYTHM PHARMACEUTICALS, INC.'s DEF 14A filed 29 Apr 2025 (accession 0001558370-25-005818).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001558370-25-005818). These figures come from RHYTHM PHARMACEUTICALS, INC.'s DEF 14A filed 29 Apr 2025 (accession 0001558370-25-005818).
| Component | Amount |
|---|---|
| Salary | $740,472 |
| Stock awards | $4,382,955 |
| Option awards | $8,784,115 |
| Cash incentive | $744,135 |
| Other | $12,065 |
| Total | $14,663,742 |
FAQ
See also: RYTM ticker page